首页|HPLC法测定二丁酰环磷腺苷钙原料药中的有关物质

HPLC法测定二丁酰环磷腺苷钙原料药中的有关物质

扫码查看
建立了 HPLC法测定二丁酰环磷腺苷钙(1)原料药中的有关物质,分别为2'-O-单丁酰环磷腺苷钠(3)、N6-单丁酰环磷腺苷钠(4)、环磷腺苷(5).采用ODS Hypersil色谱柱(4.6 mm×200 mm,5 μm),以0.1 mol/L磷酸二氢钾溶液和甲醇(体积比600∶400)为流动相,检测波长为273 nm;柱温为30 ℃;流速为1.0 mL/min.建立了加校正因子的主成分自身对照法测定3种已知杂质,确定了 3、4、5相对主成分的校正因子,分别是1.7、0.9、1.4.结果显示,二丁酰环磷腺苷钠(2)和3、4、5分别在0.1~20、4~20、1~20、0.1~2μg/mL内线性关系良好.3、4、5的平均加样回收率(n=2)分别为 101.0%、98.5%、99.7%,精密度 RSD(n=6)分别为 0.1%、0.2%、0.1%,重复性 RSD(n=6)分别为 1.5%、1.6%、2.5%.3、4、5和1的检测限分别为0.2、0.1、0.1、0.2ng.该方法专属性好、准确度和灵敏度高,为1的质量研究提供了参考.
Determination of Related Substances in Calcium Dibutyryladenosine Cyclophosphate Bulk Drug by HPLC
An HPLC method was established to determine the related substances in calcium dibutyryladenosine cyclophosphate(1)bulk drug,which were sodium 2'-O-monobutyryladenosine cyclophosphate(3),sodium N6-monobutyryladenosine cyclophosphate(4)and adenosine cyclophosphate(5).The ODS Hypersil column(4.6 mm×200 mm,5 μm)was used,with 0.1 mol/L potassium dihydrogen phosphate solution-methanol(600∶400)as the mobile phase.The detection wavelength was 273 nm,the column temperature was 30 ℃ and the flow rate was 1.0 mL/min.A main component self-compare with correction factor method was established to determine three known impurities,and the correction factors of impurities 3,4,and 5 to the principal component were determined to be 1.7,0.9,and 1.4,respectively.The results showed that it was linear for sodium dibutyryladenosine cyclophosphate(2),3,4,5 in the ranges of 0.1-20,4-20,1-20,0.1-2 μg/mL,respectively.The average recoveries(n=2)of 3,4 and 5 were 101.0%,98.5%,and 99.7%,respectively,and the precision RSDs(n=6)were 0.1%,0.2%,and 0.1%,respectively.The repeatability RSDs(n=6)were 1.5%,1.6%,and 2.5%,respectively.The detection limits for 3,4,5,and 1 were 0.2,0.1,0.1,and 0.2 ng,respectively.This method has good specificity,accuracy,and sensitivity,which can provide a reference for quality research of 1.

calcium dibutyryladenosine cyclophosphateHPLCrelated substancemain component self-compare with correction factor method

孙珍、徐明明、严翠霞、郑璐侠、邵泓

展开 >

上海市食品药品检验研究院,国家药监局治疗类单抗质量控制重点实验室,上海 201203

二丁酰环磷腺苷钙 HPLC 有关物质 加校正因子的主成分自身对照法

2024

中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCD
影响因子:0.487
ISSN:1001-8255
年,卷(期):2024.55(1)
  • 9